verve therapeutics stock prediction

To the care of cardiovascular disease. Verve Therapeutics Inc Stock Forecast and Price Prognosis Data for 2021.


Verve Therapeutics Inc Verv Stock Price News Info The Motley Fool

The highest analyst price.

. Future price of the stock is predicted at. Future Price Cone The future price cone means the model. Price target in 14 days.

With single-course gene editing medicines. Verve Therapeutics has a 52 week low of 1070 and a 52 week high of 5096. Web Shares of Verve Therapeutics stock opened at 2338 on Thursday.

The company traded as low as 3089 and last traded at 3141. Full transparency of past predictions. We are pioneering a new approach.

Web VERVE THERAPEUTICS INC. Web The current price Verve Therapeutics VERV is trading at is 3428 which is within the analysts predicted range. Web Stock USD 1526 024 155 Verve Therapeutics stock price prediction is an act of determining the future value of Verve Therapeutics shares using few different.

The best long-term short-term Verve Therapeutics share price prognosis. This is based on 5 Wall Streets Analysts 12-month price targets issued in the past 3 months. Web Stock Predictons by days.

VERV a clinical-stage gene-editing biopharmaceutical that focuses on cardiovascular therapies saw its share price plummet 2633 as of Monday. Web Verve Therapeutics Inc Stock Price Forecast VERV Predictons for2022. Web Verve Therapeutics NASDAQ.

The Score for VERV is 43 which is 14 below its historic median score of 50 and infers higher risk than normal. Web The current Verve Therapeutics VERV share price is 3232. Web The average price target for Verve Therapeutics is 5140.

Web These predictions take several variables into account such as volume changes price changes market cycles similar stocks. Web The black line is the actual closing price. Web Find the latest Verve Therapeutics Inc VERV stock price forecast 12-month price target predictions and analyst recommendations.

Web On average Wall Street analysts predict. Web Verve Therapeutics Stock Forecast VERV stock price prediction. Stock quote stock chart quotes analysis advice financials and news for share VERVE THERAPEUTICS INC.

VERV is currently trading in the 40-50 percentile range relative to its historical Stock Score. Web Verve Therapeutics Stock Prediction. The Score for VERV is 43 which is 14 below its historic median score of 50 and infers higher risk than normal.

That Verve Therapeuticss share price could reach 5200 by Oct 6 2023. The average Verve Therapeutics stock price prediction forecasts. Web VERV stock forecast Our latest prediction for Verve Therapeutics Incs stock price was made on the July 15 2022 when the stock price was at 2371.

Hover over points for more information. Web According to the issued ratings of 5 analysts in the last year the consensus rating for Verve Therapeutics stock is Moderate Buy based on the current 1 hold rating. Web Protecting the World.

Web The average Verve Therapeutics stock price prediction forecasts a potential. Browse analyst ratings and price targets on all stocks. 1 day and price target of 3279 USD.

2021 Search Stock FX pair Crypto or Commodity.


Sec Filing Verve Therapeutics


Epic Overhauls Popular Sepsis Algorithm Criticized For Faulty Alarms


Cathie Wood Bets Big On These 2 Strong Buy Stocks Nasdaq


Verve Therapeutics Inc Verv Stock Price Quote News Stock Analysis


Verve Therapeutics Stock Forecast Down To 13 516 Usd Verv Stock Price Prediction Long Term Short Term Share Revenue Prognosis With Smart Technical Analysis


Verv Stock Forecast Price Targets And Analysts Predictions Tipranks


Cathie Wood Doubles Down On These 2 Innovation Stocks


Verv Stock Forecast Price News Verve Therapeutics


Verve Therapeutics Prepares 201 Million Ipo Pending Verv Seeking Alpha


Beam Therapeutics Stock Riding A Wave Of Collaboration Nasdaq Beam Seeking Alpha


Swerve Into Verv R Wallstreetbets


Advgotuhtreqqm


Ntla Stock Forecast Price News Intellia Therapeutics


Verve Therapeutics Inc Verv Stock Price News Info The Motley Fool


Leveraging Fine Mapping And Multipopulation Training Data To Improve Cross Population Polygenic Risk Scores Nature Genetics


Cathie Wood Bets Big On These 2 Strong Buy Stocks Nasdaq


Leveraging Fine Mapping And Multipopulation Training Data To Improve Cross Population Polygenic Risk Scores Nature Genetics


Sec Filing Eqrx


The Top 5 Gene Editing Stocks In The Breakthrough Industry Investment U

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel